Ryan Bailey, MA, Senior Clinical Researcher, Rho

Are ‘Patient-Centric’ Clinical Trials More than a Buzzword?

It’s not a new idea, but meaningful adoption of so-called “patient-centric” trials has been a little slow out of the gate, industry experts say. “We’ve heard this term kicked around for a while, but it feels like people are talking about it a lot more now,” says Ryan Bailey, MA, senior clinical researcher with Rho. […]

Guest Blogger Angela Roberts, Head of CRA Recruitment, CRAresources

What About Making Professional Certification Mandatory?

Not long ago, my house’s main electrical panel box had suffered significant damage during a hurricane, and I realized it was extremely dangerous. Not only did it need to be completely replaced, but I knew my family’s safety was on borrowed time… I felt my house was going to burst into flames at any moment. […]

Allison Trainor, MPH, CPH, CCRC, UF Health Cancer Center in Florida

IRBs Don’t Have to be the Enemy

The upswing in multisite studies is making coordination between sites and institutional review boards (IRBs) simultaneously more important and more challenging, says Allison Trainor, MPH, CPH, CCRC, a clinical research coordinator at UF Health Cancer Center in Florida. It’s all too common for a site to find itself in a classic Catch-22 where there are […]

ACRP Alliance Partner

ACRP Announces Program Recognizing Clinical Research Organizations Who Support Excellence in Clinical Research

The Association of Clinical Research Professionals (ACRP) today announces a new initiative to recognize organizations who support ACRP’s mission to promote excellence in clinical research. Organizations supporting ACRP’s mission can now showcase their alignment with ACRP, and enjoy exclusive partner benefits, through the just-launched ACRP Alliance Partner program. “We are grateful for the many organizations […]

FDA Logo

Industry Applauds Selection of Gottlieb to Helm FDA

After a search that reportedly included a number of twists and turns, President Donald Trump has nominated Dr. Scott Gottlieb to be the next U.S. Food and Drug Administration (FDA) Commissioner. Gottlieb, a cancer survivor, is clinical assistant professor at New York University and health information technology adviser for the U.S. Department of Health and […]